Cargando...
Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population
BACKGROUND: A brand-name version of colchicine (Colcrys) was introduced after its manufacturer conducted a clinical trial in acute gout patients, leading to higher prices for this drug. OBJECTIVE: We analyzed the impact of the new single-source colchicine product on prescribing and patient health sp...
Gardado en:
| Publicado en: | J Gen Intern Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4617917/ https://ncbi.nlm.nih.gov/pubmed/25855479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11606-015-3285-7 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|